MENU CLOSE
About Us

Who We Are

Our Social Responsibility

Events

Exhibitions

Activeties

Members

Hospitals

Individuals

Companies

Member Benefits

 
Bio-medical projectsi

State Key Laboratory of Biotherapy

Cooperation

Achievement Exhibition

Scimea Journals

Signal Transduction and Targeted Therapy

News

News Information

 
Home   >  News
03 Sep 2020
514
MedComm | Transgenic zebrafish for modeling hepatocellular carcinoma
SCIMEA

Liver cancer is the third leading cause of cancer‐related deaths throughout the world, and more than 0.6 million people die from liver cancer annually. Therefore, novel therapeutic strategies to eliminate malignant cells from liver cancer patients are urgently needed. In this review, Prof. Joji Nakayama summarizes the current knowledge of epidemiological data and genetic alterations in hepatocellular carcinoma (HCC) and zebrafish models of HCC to help find potential therapeutic strategies for targeting HCC. 


image.png


Recent advances in high‐throughput genomic technologies have identified de novo candidates for oncogenes and pharmacological targets. However, testing and understanding the mechanism of oncogenic transformation as well as probing the kinetics and therapeutic responses of spontaneous tumors in an intact microenvironment require in vivo examination using genetically modified animal models. The zebrafish (Danio rerio) has attracted increasing attention as a new model for studying cancer biology since the organs in the model are strikingly similar to human organs and the model can be genetically modified in a short time and at a low cost. This review summarizes the current knowledge of epidemiological data and genetic alterations in hepatocellular carcinoma (HCC), zebrafish models of HCC, and potential therapeutic strategies for targeting HCC based on knowledge from the models (Fig. 1).


image.png


Fig. 1  Transgenic Zebrafish models of HCC



Article Access: https://onlinelibrary.wiley.com/doi/10.1002/mco2.29



Website for MedComm: https://onlinelibrary.wiley.com/journal/26882663

Looking forward to your contributions.





Interview | Nobuyuki Watanabe: More Cooperation Desired between Southwest China and Japan
International Exchange | Expert Team of America Mount Sinai Hospital Comes to Visit
Breaking News! First Publication of Molecular Biomedicine——Structural characterization of the C-terminal domain of SARS-CoV-2 nucleocapsid protein
New Year Greetings for 2020
​ 2019 National Symposium of VATS and Minimally Invasive Thoracic Surgery Held in Sichuan
Latest Events Journals News Members About Us Home
Contact Us

Address: No. 1103-1105, Building 6, S2, Global Center, High-tech Zone, Chengdu

Email: scimea@163.com 

Tel: (0086-)028-63859818   

Fax: (0086-)028-63859818   

Contact: (0086-)19113901604 (wechat:19113901604)


Follow Us
Copyright © 2009-2019 SCIMEA. All rights reserved 蜀ICP备19011649号-1